Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1807 of 5804
-
Can Youth-Led HIV testing programs last? new study aims to find out
Prevention OngoingSustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST), locally known as 4 Youth by Youth (4YBY) in Nigeria, builds on the investigator's previous efforts, which are detailed in ClinicalTrial ID#: NCT04070287, NCT03874663, and NCT04710784. Many adolescent…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Blockchain watchdogs take on hospital fraud in new trial
Knowledge-focused ENROLLING_BY_INVITATIONThe PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Ancho…
Sponsor: Truway Health, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New antibody drug trial offers hope for Hard-to-Treat wet AMD
Disease control Recruiting nowStudy Design This is a Single-center, Phase I/II placebo-controlled study to assess the safety and efficacy of PRL3-zumab in patients with Neovascular Age-related Macular Degeneration (nAMD). PRL3-zumab will be administered intravenously in 2-week interval for 3 doses. Normal sa…
Phase: PHASE1, PHASE2 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill aims to shrink fatty liver in 12 weeks
Disease control Recruiting nowPrimary Objective: • To evaluate the efficacy of HP515 tablets in participants with non-alcoholic fatty liver disease. Secondary objectives: * To evaluate the safety of HP515 tablets in participants with non-alcoholic fatty liver disease; * To evaluate the pharmacokinetic of H…
Phase: PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Shockwave and cold combo may ease stroke shoulder pain
Symptom relief CompletedThis study aims to find out whether combining two physical therapy treatments - Extracorporeal Shockwave Therapy and Cryoflow Therapy - can help reduce shoulder pain and improve function in patients who have developed rotator cuff tendonitis after a stroke. Participants will be d…
Phase: NA • Sponsor: MTI University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New monitor aims to stop dangerous blood pressure drops during ICU dialysis
Disease control Recruiting nowThis single-center, crossover randomized controlled trial (HyPIR-ICU) investigates whether a Hypotension Prediction Index (HPI)-guided management strategy can reduce intradialytic hypotension (IDH) during prolonged intermittent renal replacement therapy (PIRRT) in critically ill …
Phase: NA • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Lying on your back vs. your side: which is safer for kidney surgery?
Symptom relief Recruiting nowThis study aims to find out which surgical position is safer and works better for patients candidate to robot-assisted partial nephrectomy (RAPN) - a minimally invasive procedure to remove a small kidney tumor while preserving healthy kidney tissue. During this operation, the pa…
Phase: NA • Sponsor: Niguarda Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Pill vs. shot: which blood thinner better prevents deadly clots after emergency surgery?
Prevention Recruiting nowThe goal of this clinical trial is to learn if rivaroxaban works better than enoxaparin to prevent deep vein thrombosis (DVT) after emergency exploratory laparotomy in adults. It will also learn about the safety of rivaroxaban compared to enoxaparin. The main questions it aims t…
Phase: PHASE4 • Sponsor: Mayo Hospital Lahore • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
New anxiety drug shows promise in early trial
Symptom relief Recruiting nowA placebo-controlled superiority design was used to evaluate the efficacy of 40 mg/ day of Crisugabalin capsules in the treatment of GAD.
Phase: PHASE2 • Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New blood markers could spot dangerous pregnancy complication earlier
Diagnosis Recruiting nowhis study investigates the effectiveness of three specific biological markers (biomarkers) in the blood-the sFlt-1/PlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)-to better diagnose and monitor preeclampsia. Preeclampsia is a serious pregnancy complication characte…
Sponsor: Ammar Jassim Abed • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Heart study tests tailored drugs for mysterious chest pain
Knowledge-focused Recruiting nowCOMA.NET (Coronary Microcirculation Analysis Network) is a prospective, randomized, open-label, parallel-group clinical trial designed to determine whether endotype-guided pharmacotherapy is superior to standard care in improving quality of life in patients with ischemia with non…
Phase: NA • Sponsor: Medical University of Bialystok • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New clinic aims to tackle muscle wasting in COPD patients
Disease control Recruiting nowSarcopenia, or skeletal muscle loss, impacts up to 40% of COPD patients and is a major cause for morbidity and mortality. Despite the high clinical significance of sarcopenia in COPD, the diagnosis remains elusive because accurate measures of skeletal muscle are not tested during…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study tests simpler abortion pill regimen for early pregnancy
Disease control Not yet recruitingThe goal of this study is to evaluate the effectiveness, non-inferiority, and side-effect profile of an updated misoprostol-only regimen, as compared to the combined mifepristone-misoprostol regimen, among people seeking medication abortion (MAB) through 77 days of pregnancy in t…
Phase: PHASE4 • Sponsor: Ibis Reproductive Health • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New miRNA test could spot hidden virus after transplant
Diagnosis Not yet recruitingHuman cytomegalovirus (HCMV) infection is one of the most common and serious complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Standard monitoring uses HCMV DNA testing, but this method may not detect the virus early enough to guide timely treatm…
Sponsor: Ting YANG • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New study tracks how well risankizumab tames ulcerative colitis in daily life
Disease control Recruiting nowUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess the change in disease activity of risankizumab treatment in adult participants with moderate to …
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Sigh of relief: new breathing strategy may cut lung risks after heart surgery
Disease control Recruiting nowThe purpose of this trial is to investigate whether sigh ventilation strategy, combining sigh breaths, low tidal volume, and moderate PEEP levels, protects against major pulmonary complications within the first 7 postoperative days after cardiac surgery, as compared with conventi…
Phase: NA • Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
AI brain scans could revolutionize MS care
Knowledge-focused ENROLLING_BY_INVITATIONThe goal of the PROCLAIM study is to assess the effectiveness of quantitative brain MRI, as measured by icobrain mr, on the detection of disease activity in multiple sclerosis, including the identification of smouldering disease, and the downstream effects on clinical decision ma…
Phase: NA • Sponsor: icometrix • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New vaccine trial targets deadly diarrhea bug
⭐️ VACCINE ⭐️ Recruiting nowPhase 1 trial to evaluate the Safety and Immunogenicity of Inventprise's (IVT) Shigella-04 in Healthy Young Adults
Phase: PHASE1 • Sponsor: Inventprise Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:58 UTC
-
Brain scans may predict recovery from ICU delirium in lung failure patients
Knowledge-focused TerminatedEarly cognitive assessment of critically-ill acute respiratory distress syndrome (ARDS) patients with delirium using a multidimensional electrophysiological evaluation battery (mEEG) to identify and characterize the neural correlates of cognitive dysfunctions associated with deli…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
No more needles or anesthesia: new stool test could detect stomach bug in kids
Diagnosis Recruiting nowHelicobacter pylori infection is a widespread bacterial disease affecting nearly half of the world's population. In children, the infection displays distinct features versus adults, with lower prevalence, variable symptoms, and differing endoscopic and histological appearances. …
Sponsor: Poitiers University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC